MeCRU Research Unit (MeCRU), at SMU has been officially launched as the research site for Phase III Paediatric COVID-19 Vaccine study conducted by the Numolux Group and Sinovac on 10 September 2021. The very first child and the second one had the honor to receive their jabs which kick started the study.
SMU honours women advancing leadership and excellence
Sefako Makgatho Health Sciences University (SMU) celebrated women whose leadership, resilience and achievements continue to shape the University and wider society at the VC’s SMU Women in Leadership Dinner 2026, held as part of Women’s Month. Hosted by Acting...
